31.10.2013 22:35:00

Vantage Oncology, LLC -- Moody's affirms Vantage's B2 CFR following proposed $50 million of tack-on notes; outlook stable

Approximately $325 million of debt affected

Vollständigen Artikel bei Moodys lesen